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Background: Primary intrathoracic liposarcoma is an extremely rare malignancy as well as a rare histologic subtype
of intrathoracic sarcoma. Relatively few reports appear in the world literatures. We explored the clinicopathologic
features and prognostic factors of this tumor in this study.
Methods: We retrospectively analyzed the clinicopathological data of 23 patients with primary intrathoracic
liposarcoma who were treated in Shanghai chest Hospital affiliated to Jiao Tong University, from January 2003 to
March 2013. These patients were classified into three groups according to the distinct tumor locations, including
mediastinum, pleura and lung liposarcoma. Also, these patients could be divided into four types, including
well-differentiated, myxoid, dedifferentiated and pleomorphic liposarcoma. The influences of age, sex, tumor
size, tumor location, tumor histologic type and therapy on the prognosis of the patients were analyzed.
Results: There were no significant difference for survival among distinct liposarcoma locations. However,
significant difference for survival among distinct liposarcoma types were observed. Poor disease-free survival
(DFS) was observed in the myxoid, pleomorphic and dedifferentiated types as compared to well-differentiated
type (P = 0.038). Inferior overall-survival (OS) was observed in dedifferentiated, pleomorphic and myxoid types
relative to well-differentiated type (P = 0.027). The radical surgery was a favorable prognostic factor for OS, as
demonstrated by the better OS of the radical surgery group as compared to that of the non-radical surgery group
( P = 0.029). Notably, there were no significant differences for DFS and OS in other clinical parameters including
tumor size, gender and age. In addition, radiotherapy and/or chemotherapy could not improve the prognosis of
the patients receiving non-radical surgery or suffering from relapse.
Conclusions: The histological type and the radical surgery are the factors that influence the behavior and
prognosis of liposarcoma. In general, radiotherapy and chemotherapy are believed to be ineffective therapeutic
modalities for survival. So it is essential to completely resect the primary intrathoracic liposarcoma as radical cure
of the disease.
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Liposarcoma most commonly arises in the retroperito-
neum or thigh, but can also involve numerous other
anatomic sites, such as the inguinal area, popliteal fossa,
neck, as well as the genitourinary and aerodigestive
tracts. However, primary intrathoracic liposarcoma is* Correspondence: h_zhao28@163.com
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unless otherwise stated.very rare and only a few isolated cases have been
reported [1,2].
Liposarcoma has been subclassified histologically into
well-differentiated, myxoid, pleomorphic, and dedifferen-
tiated types according to the 2012 NCCN classification
of liposarcoma.
According to location classification, mediastinal liposar-
comas are extremely rare, making up from 0.1%–0.75%
of all mediastinal tumors [3]. The pleural and pulmon-
ary liposarcoma are more scarce location. Hitherto, thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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subtypes and different locations is still unclear. Therefore,
we carried out this study to explore the correlation
between the survival and distinct tumor locations/histo-
logical types of this rare malignancies for the first time.
Methods
Patients
The 23 patients who received primary intrathoracic lipo-
sarcoma resection in Shanghai Chest Hospital affiliated
to Shanghai Jiao Tong Universityfrom January 2003 to
March 2013 were included in this study. All specimens of
these patients were confirmed by experienced pathologists.
Clinical data
In these 23 cases, 10 cases were mediastinal liposarcoma,
9 cases were pleural liposarcoma, and 4 cases were lung
liposarcoma. 8 cases were type of well-differentiated
liposarcoma, 8 cases were type of myxoid liposarcoma,
4 cases were type of de-differentiated liposarcoma, 3
cases were type of pleomorphic liposarcoma. Of these
cases, 12 were males, 11 were females, and the ratio of
the male to female was 1.1:1. Patients ranged in age
from 16 to 72 years with a median age of 49 years.
Tumor size was calculated by the maximum diameter.
The median size of these 23 patients was 8 cm (range 4
to 39 cm). Among these cases, tumor sizes of totally11
cases were > 8 cm.
The most common presenting symptom include chest
pain, cough, dyspnea on exertion and shortness of breath,
on occasion, patients may be asymptomatic. Contrast-
enhanced chest CT scans and X-ray were performed
for all patients. If the lesion was suspected violations
of the heart or great vessels, the MRI examination was
performed.
Therapy
Primary intrathoracic liposarcoma resection was performed
in all the 23 patients in this study. All of them under-
went median sternotomy or thoracotomy. Lobectomy
and systematic lymph node dissection were performed
in pulmonary liposarcoma group. Among 17 patients,
who received radical surgery, 9 patients suffered from
relapse. Among these 9 patients, metastatic cases received
chemotherapy or/and radiotherapy. Adjuvant radiotherapy
or/and salvage surgery were made depending on individ-
ual situation among local recurrence cases (Table 1). Due
to advanced disease, 6 cases were received non-radical
surgery, along with chemotherapy or/and radiotherapy
(Table 2).
Follow-up
All patients were followed up (follow-up with investigation
letter or telephone,) until 29 March 2013. The range offollow-up time was from 7 to 90 months, with median
follow-up period of 16 months. At the end of the observa-
tion, 10 patients died and 13 patients were still alive.
Statistical analysis
For survival analysis, OS was measured as time from
disease diagnosis to death from tumor, or censoring for
patients alive at the time of their final follow-up. DFS
was defined as time from complete resection until local
recurrence or metastasis. OS and DFS were analyzed
by means of Kaplan-Meier method followed with log-
rank test. Additionally, for the categorical parameters,
Chi-square test was performed. Statistical analyses were
carried out with use of SPSS software (version 16.0,
Chicago, IL) and R (version 2.15.0, www.r-project.org).




Liposarcoma has been subclassified histologically into well-
differentiated, myxoid, dedifferentiated and pleomorphic
types by 2012 Soft Tissue Sarcoma of NCCN Clinical
Practice Guidelines in Oncology.
Of the 23 patients in the study, 8 cases were well-
differentiated liposarcomas. In brief histologic features
exhibited large areas of mature adipose tissue, with scarce
lipoblasts. Immunohistochemical study showed S-100 was
positive in all the 8 cases, while both MDM2 and CDK4
were positive in 6 cases.
The 8 myxoid cases contained a mixture of quite uni-
form round to oval mesenchymal cells and small, often
signet ring lipoblasts in a myxoid stroma with delicate
arborizing vasculature and focal mucin pools. Immunohis-
tochemical study showed that in all the 8 cases S-100 was
positive, while both Actin and HMB45 were negative.
The 4 dedifferentiated liposarcomas were characterized
by areas of well-differentiated liposarcoma showing transi-
tion to areas of nonlipogenic spindle cell sarcoma of
varying morphology and grade. Immunohistochemical
study showed protein S-100 was focally expressed in all
the 4 cases, while both MDM2 and CDK4 were positive
in 3 cases.
The 3 pleomorphic cases had a predominance of spindle
cells, with necrosis and widespread anaplasia. Bizarre
lipoblasts were present as were multinucleated floret-like
giant cells. Due to lack of obvious value, immunohisto-
chemical was not studied in the 3 cases.
Imaging findings
Imaging features depend directly on the tumor components
and types. Well-differentiated liposarcomas resemble lip-
omas on both CT and MRI. They contain a large amount
of fat, usually more than 75% of their volume. Fibrous septa
Table 1 Basic characteristics of 17 patients received complete surgical excision
Patient id Age Gender Tumor size (cm) Location Type Local recurrence Metastasis Protocol at relapse DFS (mo) DFS status OS (mo) OS status
1 19 M 12.00 Pleura Well-differentiated Yes No S 48 Disease relapse 56 Censored
2 30 F 6.00 Pleura Well-differentiated No No 48 Censored 48 Censored
3 36 F 14.00 Mediastinum Well-differentiated Yes No S 36 Disease relapse 60 Censored
4 60 M 28.00 Pleura Well-differentiated No No 43 Censored 43 Censored
5 63 M 6.00 Mediastinum Well-differentiated No No 8 Censored 8 Censored
6 72 M 16.00 Mediastinum Well-differentiated No No 48 Censored 48 Censored
7 16 F 7.00 Mediastinum Myxoid No No 36 Censored 36 Censored
8 20 F 4.00 Pleura Myxoid Yes No S + RT 47 Disease relapse 90 Censored
9 44 M 8.00 Pulmonary Myxoid No No 13 Censored 13 Censored
10 47 M 8.00 Mediastinum Myxoid Yes No S 12 Disease relapse 27 Dead
11 54 M 16.00 Pleura Myxoid No No 26 Censored 26 Censored
12 61 F 12.00 Pulmonary Myxoid No To liver CT 3 Disease relapse 14 Dead
13 41 M 16.00 Pleura Dedifferentiated Yes No S 10 Disease relapse 15 Dead
14 53 M 8.00 Pleura Dedifferentiated No To lung CT 6 Disease relapse 11 Dead
15 59 F 7.00 Pulmonary Dedifferentiated Yes No RT 6 Disease relapse 9 Dead
16 64 M 6.00 Mediastinum Dedifferentiated No No 12 Censored 12 Censored
17 49 M 4.50 Pulmonary Pleomorphic No To bone RT + CT 13 Disease relapse 16 Censored
















Table 2 Basic characteristics of 6 patients received non-radical surgical excision
Patient id Age Gender Tumor size (cm) Location Type Metastasis Adjuvant protocol OS (mo) OS status
1 50 F 8.00 Mediastinum Well-differentiated No No 60 Dead
2 61 M 39.00 Pleura Well-differentiated No No 18 Censored
3 59 F 10.00 Mediastinum Myxoid To lung CT 10 Dead
4 45 F 16.00 Pleura Myxoid To lung CT 7 Dead
5 42 F 8.00 Mediastinum Pleomorphic To bone RT + CT 13 Dead
6 23 F 20.00 Pleura Pleomorphic No RT 14 Dead
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lipomas. Myxoid liposarcomas contain lipoblastic mes-
enchymal cells and a plexiform capillary network, all
set in a myxoid matrix. Because the fat content is often
less than 10–25% of the tumor volume, CT might not
show the typical features of lipomatous tumors. Pleo-
morphic and dedifferentiated liposarcomas have the same
radiological appearances. Both types usually contain little
or no fat. For this reason, it is often impossible to differen-
tiate them from other soft-tissue sarcomas.
MRI represents the gold standard for diagnostic evalu-
ation and preoperative planning due to its superior defin-
ition of the tumor invasion of vessels in the mediastinum
and the thoracic inlet.Treatment methods
Complete surgical excision was attempted in 17 of the
total 23 patients. Unfortunately, 9 patients of these 17
patients suffered from relapse. Among these cases, 2
cases of well-differentiated type belonging to mediastinal
and pleural groups respectively were local recurrence. 2
cases of myxoid type were local recurrence, each one in
mediastinal or pleural group and 1 case of myxoid type
with metastases of the liver in pulmonary group. 3 cases
of dedifferentiated type were relapsed, including 1 local
recurrence in the pleural group and 1 in the pulmonary
group, and 1 case in the pleural group with metastases
of the lung .1 case of pleomorphic type had metastases
of the bone, belonging to pulmonary group. The lymph
nodes were negative in all the cases of pulmonary group.
Among above 9 patients, 3 metastatic cases did not
respond to chemotherapy or/and radiotherapy. For the
remaining 6 local recurrence cases, adjuvant radiother-
apy or/and salvage surgery were made depending on
the individual situation (Table 1).
In addition, 6 of the total 23 patients received non-
radical therapy, including 2 well-differentiated, 2 myxoid
and 2 pleomorphic cases (Table 2). The 2 myxoid and 2
pleomorphic patients died approximately one year after
surgery. 1 well-differentiated patient died in 60 months,
while the other is still alive. It was noted that the myxoid
and pleomorphic types basically did not respond to
chemotherapy or/and radiotherapy.Survival analysis of the patients
The median follow-up time of the 23 patients was 16
months (range: 7 months-90 months). The estimated 2-year
DFS and OS rates were 62.70% (95% CI, 42.90-91.80%)
and 61.70% (95% CI, 43.90-86.80%) respectively.
No significant differences for DFS and OS among distinct
tumor locations were observed. Nevertheless, there were
significant differences for DFS and OS among distinct
liposarcoma types. Poor DFS was observed in the myxoid
(median DFS 47 months), dedifferentiated (median DFS 6
months and pleomorphic types (median DFS 13 months)
as compared to well-differentiated type (median DFS not
reached) (P = 0.038) (Figure 1). Inferior OS was observed
in dedifferentiated (median OS 11 months), pleomorphic
types (median OS 14 months) and myxoid (median OS 27
months), compared to well-differentiated type (median
OS 60 months) (P = 0.027) (Figure 2). Notably, there were
no significant difference for the surgery protocols between
distinct liposarcoma types (Chi-square P = 0.32 for OS).
Additionally, the surgery procedure was a prognostic
factor for OS, as demonstrated by the poor OS in the
non-radical surgery group (median OS 13 months) as
compared to that of the radical surgery group (median
OS not reached) (P = 0.029) (Figure 3). Notably, there
were no significant differences for DFS and OS in other
clinical parameters including tumor size, gender and
age (Table 3).
Discussion
Liposarcoma is the most common soft-tissue sarcoma
and accounts for approximately 20% of all mesenchymal
malignancies [4]. Liposarcomas are usually found in adults
and occur rarely in children. About 90–95% of these
tumors occur in the trunk, the extremities or retroperito-
neum. Primary intrathoracic liposarcomas are unusual,
representing 2.7% of all locations [5].
Liposarcomas originate from primitive mesenchymal
cells rather than from mature fat cells [6]. Enlarged or
irregular adipocyte nuclei, multivacuolated cells, or scler-
osing areas are each highly suggestive that the neoplasm
in question is indeed a liposarcoma.
Other sarcomas that may be confused with liposarcoma
include malignant fibrous histiocytoma, in which bizarre
pleomorphic giant cells may be mistaken for pleomorphic
Figure 1 Disease-free survival curves according to the tumor type. Poor DFS was observed in the myxoid, dedifferentiated and pleomorphic
types as compared to well-differentiated type (P = 0.038).
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often correctly diagnosed by percutaneous biopsy, or even
misdiagnosed.
Perhaps because of the expansile rather than infiltrative
growth pattern of most of these tumors, patients often
presented with few symptoms despite having large or
even massive tumors. The mean tumor size in our
study is 12.15 ± 8.2 cm. 20 patients presented symptoms
usually related to respiratory compromise, including chestFigure 2 Overall survival curves according to the tumor type. Inferior
relative to well-differentiated type ( P = 0.027).pain, cough, and shortness of breath. 3 patients were
asymptomatic, including one pleural well-differentiated
liposarcoma with the size of 12 cm.
Liposarcomas of the lung and mediastinum have been
reported [7], and distinction from pleural liposarcoma
with chest wall or mediastinal invasion requires careful
radiographic evaluation, surgical evaluation, or both. In
some cases it may be impossible to be certain where the
tumor is arising.OS were observed in dedifferentiated, myxoid and pleomorphic types,
Figure 3 Overall survival curves according to the surgery. The variable of surgery was a prognostic factor for OS, as demonstrated by the
poor OS in the non-radical surgery group as compared to that of the radical surgery group ( P = 0.029).
Table 3 Survival data of the patients classified by distinct factors in the study
Variable OS DFS
Case number Median OS (month) P Case number Median DFS (month) P
Age 0.566 0.516
<= 60 y 18 60 13 47
> 60 y 5 not reached 4 not reached
Gender 0.216 0.685
Male 12 not reached 11 48
Female 11 60 6 36
Type 0.027 0.038
Well-differentiated 8 60 6 not reached
Myxoid 8 27 6 47
Dedifferentiated 4 11 4 6
Pleomorphic 3 14 1 8
Location 0.713 0.136
Mediastinum 10 60 6 not reached
Pleura 9 not reached 7 47
Pulmonary 4 14 4 6
Size (ref = less 8 cm) 0.987 0.849
<= 8 cm 12 60 10 47
> 8 cm 11 not reached 7 36
Therapy 0.029
Radical 17 not reached 17 47
Non-radical 6 13 6*
*The date of DFS are not included non-radical cases.
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group of our data presented larger tumor size than that
of the other two groups. But the tumor size was not the
factor of the prognosis (p = 0.987). Pleural liposarcoma
always reach large proportions because they grow in-
sidiously in areas that are not accessible to physical
examination.
Pulmonary lesions are usually metastatic. Metastasis
to various structures including lung, pleura, liver and
bone are described, specially in the poor differentiated
varieties [8]. For only 4 case in all of the pulmonary
liposarcoma in our study, one case was still alive after
13 months follow-up without disease, one case had
local recurrence, and the other two cases had metastases
of liver and bone. But the lymph nodes were negative
in all the cases of pulmonary group. This phenomenon
implies that liposarcoma is metastasized through blood
rather than lymph node.
In previous reports, the clinical behavior of medias-
tinal liposarcomas has been variable but ultimately fatal
in most cases. In Okurnori’s review [9], 10 of 14 patients
died after a mean interval of 2.7 years. In Cicciarelli’s
series [10], four of seven patients died following resection
after a mean of 1.5 years. For 9 of mediastinal liposarco-
mas in our data, four cases died, in which three cases had
non-radical surgery. All the three cases were implied
tumor invasion of vessels by MRI before surgery. It is
consistent with the result of the previous study that
non-radical resection is an unfavorable factor of the
overall survival.
Although sometimes the location of the liposarcoma is
difficulty to be determined, our data show that there is
no difference for DFS (p = 0.136) and OS (p = 0.713) among
the three tumor locations.
Our study demonstrates that the most common
histologic types of intrathoracic liposarcoma appear to
be well-differentiated (34.78%, 8/23) and myxoid cases
(34.78%, 8/23), which is consistent to reports of the
literatures. All forms of liposarcoma contain lipoblasts
in varying numbers and morphologic forms; however,
the more poorly differentiated liposarcomas behave
more aggressively and local and distant complications.
Obviously, radical surgery is a favorable prognostic fac-
tor as demonstrated by the better OS of patients receiving
radical surgery than that of patients receiving non-radical
surgery (P = 0.029). In the radical group, different types
of liposarcomas showed different DFS (P = 0.038). In
the non-radical group, radical surgery was not performed
mainly due to the invasion of tumors into adjacent vital
structures, such as heart, great vessels, trachea, bronchi
and esophagus. Although the size of the non-radical group
tumors are all equal to or larger than the median size
of all the tumors, the size is not the factor contributed
to incomplete surgical excision in our opinion. Contrast-enhanced chest CT scans and MRI examination are con-
sidered important to determine the complete extent of the
mass lesion, which has significant influence on surgical
planning. In patients where surgical resection is incom-
plete, a CT scan and MRI frequently defines the size and
location of residual tumor.
Well-differentiated liposarcoma is a low or intermediate
grade malignancy tumor. In our study, one well-differenti-
ated case died of compressive complication. This patient
was performed not radical but non-radical resection
due to complete surgical removal was complicated by
the lobules of tumor to wrap around great vessels and
mainstem bronchi. Notably, the other well-differentiated
case receiving non-radical resection without adjuvant
therapy, was still alive and without the tumor enlargement
after 18 months follow-up. The remaining well-differenti-
ated cases who were performed radical surgery, were all
still alive. Our data demonstrated the well-differentiated
type is a good prognostic factor.
In our study, among 8 myxoid cases, 4 cases died. One
cases died of metastases of liver, two cases died of
metastases of lung, the other one died of compressive
complication.
Our data show myxoid liposarcoma was prone to
metastase and basically had no chemotherapy or/and
radiotherapy response, except local recurrence of radical
surgery case had salvage surgery and radiotherapy, he
was still alive.
Radiotherapy had also been of some value as an adju-
vant treatment for the myxoid type [11-13]. Since the
limited data, we didn’t draw the conclusion.
The pleomorphic and de-differentiated types are regarded
as highly malignant tumors with a tendency towards local
recurrence and metastasis.
Two patients had non-radical resection and one patient
had distant bone metastases in all three pleomorphic
liposarcoma. Although the bone metastases case was
still alive, the patient was followed up only 3 months,
and the bone lesion was not improved by therapy.
Three patients relapsed after radical surgery in four
dedifferentiated liposarcoma and they all die. Totally
seven patients of the two types cases, five patients had
died about 1 year after operation, while the other two
patients were still alive with and without disease respect-
ively. Our data provides additional evidence that the
pleomorphic and de-differentiated types are unfavorable
prognostic factors. Besides, our result suggest these two
types of liposarcomas also had no chemotherapy or/and
radiotherapy response.
The result of our study showed the histologic types
of the liposarcoma is an important prognosis factor
of OS (P = 0.027). Notably, there were no significant
difference for the surgery procedure between distinct
liposarcoma types (Chi-square P = 0.32 for OS). Therefore,
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The use of adjuvant treatment for intrathoracic lipo-
sarcoma is controversial. Doxorubicin and ifosfamide
are the most frequently used chemotherapeutic agents
in patients with intrathoracic liposarcoma [14].
Hirai et al. [15] reported in general, radiotherapy and
chemotherapy are believed to be ineffective therapeutic
modalities for survival. At present, therefore, the best
treatment for mediastinal liposarcoma should be complete
surgical resection.
In our medical center, Doxorubicin and ifosfamide are
also the most commonly used chemotherapeutic agents.
Evidence from our medical center cases reviewed here
indicates that adjuvant radiotherapy or/and chemother-
apy may not benefit patients with primary intrathoracic
liposarcoma. But the limitation presented in this study
must be considered. The population in this study was
small because the disease is rare. Future studies with
larger patient population is needed, and whether radiology
and chemotherapy seem to be effective treatment as
induction therapy can be also investigated.
Conclusions
There were no significant differences for survival among
distinct liposarcoma locations. Nevertheless, liposarcoma
types were associated with the survival. The well-differen-
tiated liposarcoma patients who received radical surgery
had the best prognosis. The histological type of the
liposarcoma and the radical surgery are the factors that
influence tumor behaviour and prognosis. In general,
radiotherapy and chemotherapy are believed to be inef-
fective therapeutic modalities for survival. So we should
try our best to completely resect the primary intrathoracic
liposarcoma.
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